Not a good buy right now for an impatient buyer: the latest earnings miss is pressuring sentiment and the short-term statistical trend outlook skews negative (next week/month).
Despite bullish longer-term moving averages, price is sitting just below/near the pivot (23.656), suggesting limited immediate upside without a clear catalyst.
With no proprietary buy signals today (AI Stock Picker/SwingMax) and no options sentiment available, the risk/reward for an immediate entry is not compelling.
Best stance now: hold/avoid initiating; only consider buying on a clear reclaim above 23.66–24.20 or a pullback closer to support (23.11/22.77).
Technical Analysis
Trend/Momentum: Mixed. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), implying an uptrend structure, but momentum is soft.
MACD: Histogram is negative (-0.0297) but contracting, which can indicate bearish momentum is fading (early stabilization), not a confirmed reversal.
RSI(6): 50.862 (neutral), showing no strong overbought/oversold edge.
Key levels:
Pivot: 23.656 (price 23.49 is slightly below—near-term bias is cautious until reclaimed)
Resistance: 24.202 (R1), 24.539 (R2)
Support: 23.109 (S1), 22.772 (S2)
Pattern-based forward odds (from similar candlesticks): ~70% chance of -0.5% next day, -3.18% next week, -3.11% next month → near-term drift lower is more likely than a quick breakout.
Analyst view remains constructive: Piper Sandler maintains Overweight and sees weakness as an entry opportunity; latest PT still above market ($26.50 vs $23.49).
Management/strategic: Appointment of a new EVP & Chief Commercial Real Estate Lending Officer could strengthen CRE lending competitiveness and loan growth execution.
Technical structure (bullish MA stack) suggests the bigger-picture trend has not broken down.
Net income: $3.403M, -0.79% YoY (slight profitability decline).
EPS: $0.47, -2.08% YoY (earnings per share modestly weaker).
Takeaway: growth is present on revenue, but earnings/EPS are not expanding—consistent with the recent “disappointing earnings” narrative and limiting urgency to buy immediately.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend: Piper Sandler kept an Overweight rating but trimmed the price target slightly to $26.50 from $27 (2026-01-30) after results; earlier they raised PT to $27 from $25 (2025-12-10).
Wall Street pro view (pros): Lower-risk balance sheet, expectation for improving core profitability/ROTC E as NIM improves and expenses remain disciplined.
Wall Street con view (cons): Near-term execution/earnings volatility is evident (recent quarter not ideal; meaningful EPS miss), which can cap upside until fundamentals re-accelerate.
Wall Street analysts forecast HNVR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HNVR is 27 USD with a low forecast of 27 USD and a high forecast of 27 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast HNVR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HNVR is 27 USD with a low forecast of 27 USD and a high forecast of 27 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 23.400
Low
27
Averages
27
High
27
Current: 23.400
Low
27
Averages
27
High
27
Piper Sandler
Overweight
downgrade
$27
AI Analysis
2026-01-30
Reason
Piper Sandler
Price Target
$27
AI Analysis
2026-01-30
downgrade
Overweight
Reason
Piper Sandler lowered the firm's price target on Hanover Bancorp to $26.50 from $27 and keeps an Overweight rating on the shares. While the quarterly results were not ideal by any means, any outsized weakness in the company's stock price should be viewed as an attractive entry point for investors, the firm argues.
Piper Sandler
Overweight
upgrade
$25 -> $27
2025-12-10
Reason
Piper Sandler
Price Target
$25 -> $27
2025-12-10
upgrade
Overweight
Reason
Piper Sandler raised the firm's price target on Hanover Bancorp to $27 from $25 and keeps an Overweight rating on the shares. The company has a lower-risk balance sheet and the firm expects core profitability to steadily march higher in coming quarters as the net interest margin improves, fee revenues benefit from higher loan sale gains and expense discipline helps to push the core ROTCE to about 11%.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for HNVR
